Ms. Geraldine Gourley, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 700 E Palisade Ave, Englewood Cliffs, NJ 07632 Phone: 201-414-7705 |
Roy Spiegel, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 616 E Palisade Ave, Englewood Cliffs, NJ 07632 Phone: 201-894-0071 |
Ms. Valerie G Finkel, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 661 E Palisade Ave, Suite 1a, Englewood Cliffs, NJ 07632 Phone: 201-470-2187 Fax: 201-568-3106 |
Gail Wilkins, LSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 51 Rock Rd, Englewood Cliffs, NJ 07632 Phone: 201-838-9535 |
Dr. Debra Lynn Kress, L.C.S.W,. PSY.D. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 510 Sylvan Ave, Suite 202, Englewood Cliffs, NJ 07632 Phone: 201-567-3772 Fax: 201-567-0056 |
News Archive
A team of surgeons and specialists at Massachusetts General Hospital is announcing an achievement in transplant surgery today, having recently performed the largest number of adult heart transplants in the country using what are known as Donation after Circulatory Death donor hearts.
Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes, researchers have shown in a new study presented at the American Thoracic Society International Conference.
Veracyte, Inc. announced today the successful completion of its Series B round, a key milestone toward the company's first product launch later this year. The South San Francisco biotechnology company is committed to pioneering molecular cytology diagnostics to improve patient care and lower health care costs. This round was led by Domain Associates with significant participation from Veracyte's founding investors including Kleiner Perkins Caufield & Byers (KPCB), TPG Biotech (TPG), and Versant Ventures.
One test that could detect four of the most common sexually transmitted infections in 30 minutes and allow them to be rapidly treated, will be developed by St George's, University of London and diagnostics company Atlas Genetics.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Merck & Co., Inc. (NYSE: MRK) today announced that the acquisition by sanofi-aventis of Merck's 50 percent interest in Merial Limited (Merial) has been completed.
› Verified 1 days ago